Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLEXJW for Intradialytic Hypotension
NCT05517993Phase 3Unknown
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Sep 2022
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of gui-lu-er-xian-jiao-wan in intradialytic hypotension (IDH) (2 arms), sponsored by Chang Gung Memorial Hospital. Primary endpoint: Intradialytic hypotension episode at 12 weeks. Status: unknown.
02
Drugs
gui-lu-er-xian-jiao-wan
03
Conditions
intradialytic hypotension (IDH)
Beyond the preview
Go deeper on NCT05517993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05517993.